Skip to main content

NeuroMetrix, Inc.

NURODelisted May 1, 2025
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001289850

NeuroMetrix, Inc. was delisted on May 1, 2025; its insiders filed their last Form 4 on May 5, 2025; 14 institutions reported holding it in 13F filings for Q1 2025, worth $599.9K in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by NeuroMetrix, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for NeuroMetrix, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for NeuroMetrix, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Katz Nancy EDirector0May 5, 20250
Higgins Thomas TSenior Vice President, CFO0May 5, 20250
Gozani ShaiPresident and CEO0May 5, 20250
Goodman DavidDirector0May 5, 20250
Van Avermaete DavidDirector0May 5, 20250
Horowitz JoshuaDirector0IndirectMay 5, 20250
Fluegel Bradley MDirector8,634May 24, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 30, 2024 (view filing)Apr 228 daysHorowitz JoshuaDirectorSSale−1.00K$4.58−$4.58K−4.1%23.4K afterAmended
Aug 27, 2021 (view filing)Aug 252 daysHiggins Thomas TSenior Vice President, CFOSSale−50.0K$10.55−$527.5K−67.9%23.7K after
Aug 13, 2021 (view filing)Aug 121 dayHiggins Thomas TSenior Vice President, CFOSSale−20.0K$13.56−$271.2K−45.8%23.7K after